Trial intelligence / Profile preview

Melatonin vs gabapentin vs dexmedetomidine for postoperative pain and anxiety after laminectomy

IRCT20141009019470N82Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of melatonin, gabapentin and dexmedetomidine in postoperative pain and anxiety disorder (3 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Patient satisfaction, Severity of pain and 1 more. Started Jul 2019; status: completed.

02

Drugs

melatoningabapentindexmedetomidine
03

Conditions

postoperative painanxiety disorder

Beyond the preview

Go deeper on IRCT20141009019470N82.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20141009019470N82.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call